Britta Spanier

1.5k total citations
32 papers, 1.0k citations indexed

About

Britta Spanier is a scholar working on Molecular Biology, Aging and Biochemistry. According to data from OpenAlex, Britta Spanier has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Aging and 7 papers in Biochemistry. Recurrent topics in Britta Spanier's work include Genetics, Aging, and Longevity in Model Organisms (12 papers), Amino Acid Enzymes and Metabolism (6 papers) and Metabolomics and Mass Spectrometry Studies (6 papers). Britta Spanier is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (12 papers), Amino Acid Enzymes and Metabolism (6 papers) and Metabolomics and Mass Spectrometry Studies (6 papers). Britta Spanier collaborates with scholars based in Germany, France and Switzerland. Britta Spanier's co-authors include Hannelore Daniel, Gábor Kottra, Pieter Giesbertz, Dietmar Weitz, Josef Ecker, Sabine E. Kulling, Sebastian T. Soukup, Inken Padberg, Dietrich Rein and Martin Klingenspor and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and Applied and Environmental Microbiology.

In The Last Decade

Britta Spanier

32 papers receiving 1.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Britta Spanier 537 226 223 129 120 32 1.0k
Bharat L. Dixit 561 1.0× 293 1.3× 178 0.8× 69 0.5× 94 0.8× 22 1.1k
John J. Thaden 470 0.9× 320 1.4× 328 1.5× 55 0.4× 29 0.2× 46 1.1k
Michael Boll 542 1.0× 206 0.9× 137 0.6× 355 2.8× 487 4.1× 34 1.3k
Masaki Mizunuma 1.1k 2.0× 469 2.1× 183 0.8× 72 0.6× 58 0.5× 52 1.6k
Elizabeth A. Schroeder 652 1.2× 439 1.9× 201 0.9× 19 0.1× 67 0.6× 12 1.0k
Christoph Ruckenstuhl 1.3k 2.3× 288 1.3× 355 1.6× 89 0.7× 289 2.4× 34 2.2k
Michael L. Goodson 1.3k 2.5× 104 0.5× 271 1.2× 133 1.0× 23 0.2× 46 1.8k
Jérôme Lapointe 720 1.3× 344 1.5× 349 1.6× 17 0.1× 59 0.5× 44 1.4k
Gordon M. Kirby 433 0.8× 34 0.2× 111 0.5× 162 1.3× 75 0.6× 50 1.1k

Countries citing papers authored by Britta Spanier

Since Specialization
Citations

This map shows the geographic impact of Britta Spanier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britta Spanier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britta Spanier more than expected).

Fields of papers citing papers by Britta Spanier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britta Spanier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britta Spanier. The network helps show where Britta Spanier may publish in the future.

Co-authorship network of co-authors of Britta Spanier

This figure shows the co-authorship network connecting the top 25 collaborators of Britta Spanier. A scholar is included among the top collaborators of Britta Spanier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britta Spanier. Britta Spanier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nies, Anne T., Jörg König, Katja Damme, et al.. (2023). Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation. Pharmacological Research. 196. 106941–106941. 4 indexed citations
2.
Spanier, Britta, Anne Laurençon, Nathalie Pujol, et al.. (2021). Comparison of lipidome profiles of Caenorhabditis elegans—results from an inter-laboratory ring trial. Metabolomics. 17(3). 25–25. 5 indexed citations
3.
Spanier, Britta, Anne Laurençon, Nathalie Pujol, et al.. (2021). Correction to: Comparison of lipidome profiles of Caenorhabditis elegans—results from an inter-laboratory ring trial. Metabolomics. 17(3). 33–33. 2 indexed citations
4.
Spanier, Britta, Roman Lang, Daniela D. Weber, et al.. (2019). Bioavailability and Biological Effects of 2-O-β-d-Glucopyranosyl-carboxyatractyligenin from Green Coffee in Caenorhabditis elegans. Journal of Agricultural and Food Chemistry. 67(17). 4774–4781. 7 indexed citations
5.
Giesbertz, Pieter, et al.. (2018). Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes. Journal of Diabetes Research. 2018. 1–9. 7 indexed citations
6.
Spanier, Britta, et al.. (2018). Proton Coupled Oligopeptide Transporter 1 (PepT1) Function, Regulation, and Influence on the Intestinal Homeostasis. Comprehensive physiology. 8(2). 843–869. 9 indexed citations
7.
Spanier, Britta, et al.. (2018). Proton Coupled Oligopeptide Transporter 1 (PepT1) Function, Regulation, and Influence on the Intestinal Homeostasis. Comprehensive physiology. 8(2). 843–869. 53 indexed citations
8.
Spanier, Britta, et al.. (2018). The Reproduction Rate of Peptide Transporter PEPT-1 Deficient C. elegans Is Dependent on Dietary Glutamate Supply. Frontiers in Molecular Biosciences. 5. 109–109. 4 indexed citations
10.
11.
Giesbertz, Pieter, Inken Padberg, Dietrich Rein, et al.. (2015). Metabolite profiling in plasma and tissues of ob/ob and db/db mice identifies novel markers of obesity and type 2 diabetes. Diabetologia. 58(9). 2133–2143. 128 indexed citations
12.
Giesbertz, Pieter, et al.. (2015). An LC-MS/MS method to quantify acylcarnitine species including isomeric and odd-numbered forms in plasma and tissues. Journal of Lipid Research. 56(10). 2029–2039. 91 indexed citations
13.
Geillinger, Kerstin E., et al.. (2014). Nrf2 regulates the expression of the peptide transporter PEPT1 in the human colon carcinoma cell line Caco-2. Biochimica et Biophysica Acta (BBA) - General Subjects. 1840(6). 1747–1754. 25 indexed citations
14.
Geillinger, Kerstin E., Katja Kuhlmann, Martin Eisenacher, et al.. (2014). Intestinal Amino Acid Availability via PEPT-1 Affects TORC1/2 Signaling and the Unfolded Protein Response. Journal of Proteome Research. 13(8). 3685–3692. 15 indexed citations
15.
Soukup, Sebastian T., et al.. (2012). Formation of Phosphoglycosides in Caenorhabditis elegans: A Novel Biotransformation Pathway. PLoS ONE. 7(10). e46914–e46914. 10 indexed citations
16.
Daniel, Hannelore, et al.. (2011). A Glutathione Peroxidase, Intracellular Peptidases and the TOR Complexes Regulate Peptide Transporter PEPT-1 in C. elegans. PLoS ONE. 6(9). e25624–e25624. 41 indexed citations
17.
Soukup, Sebastian T., et al.. (2011). Structural features and bioavailability of four flavonoids and their implications for lifespan-extending and antioxidant actions in C. elegans. Mechanisms of Ageing and Development. 133(1). 1–10. 115 indexed citations
18.
Spanier, Britta, Isabel Rubio‐Aliaga, Hao Hu, & Hannelore Daniel. (2010). Altered signalling from germline to intestine pushes daf‐2;pept‐1 Caenorhabditis elegans into extreme longevity. Aging Cell. 9(4). 636–646. 23 indexed citations
19.
Spanier, Britta, Wenjuan Liao, Hao Hu, et al.. (2009). How the Intestinal Peptide Transporter PEPT-1 Contributes to an Obesity Phenotype in Caenorhabditits elegans. PLoS ONE. 4(7). e6279–e6279. 60 indexed citations
20.
Spanier, Britta, Stephen R. Stürzenbaum, Lindy Holden‐Dye, & Ralf Baumeister. (2005). Caenorhabditis elegans Neprilysin NEP-1: an Effector of Locomotion and Pharyngeal Pumping. Journal of Molecular Biology. 352(2). 429–437. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026